Biogen
BIIB
#869
Rank
ยฃ19.96 B
Marketcap
ยฃ136.06
Share price
-0.37%
Change (1 day)
9.95%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ13.66 Billion

According to Biogen's latest financial reports the company has ยฃ13.66 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Biogen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ13.32 B14.67%
2023-12-31$ยฃ11.61 B4.97%
2022-12-31$ยฃ11.06 B36.3%
2021-12-31$ยฃ8.11 B3.57%
2020-12-31$ยฃ7.83 B-22.93%
2019-12-31$ยฃ10.17 B-0.91%
2018-12-31$ยฃ10.26 B10.14%
2017-12-31$ยฃ9.32 B-5.17%
2016-12-31$ยฃ9.82 B55.38%
2015-12-31$ยฃ6.32 B-8.92%
2014-12-31$ยฃ6.94 B32.9%
2013-12-31$ยฃ5.22 B21.3%
2012-12-31$ยฃ4.30 B4.2%
2011-12-31$ยฃ4.13 B17.14%
2010-12-31$ยฃ3.53 B-8.77%
2009-12-31$ยฃ3.86 B-2.79%
2008-12-31$ยฃ3.98 B42.89%
2007-12-31$ยฃ2.78 B-23.68%
2006-12-31$ยฃ3.65 B-8.85%
2005-12-31$ยฃ4.00 B12.62%
2004-12-31$ยฃ3.55 B-9.82%
2003-12-31$ยฃ3.94 B469.73%
2002-12-31$ยฃ0.69 B-25.61%
2001-12-31$ยฃ0.93 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
ยฃ7.21 B-47.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.10 B 17.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-ยฃ1.96 Billion-114.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ69.86 B 411.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ59.49 B 335.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ0.14 Billion-101.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ64.76 B 373.97%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
ยฃ5.05 B-63.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ1.78 B-86.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ2.73 B-79.96%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands